Sfoglia per Autore
Circulating cell-free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients
2021 A. Papatheodoridi, A. Chatzigeorgiou, L. Chrysavgis, P. Lembessis, A. Loglio, F. Facchetti, E. Cholongitas, M. Koutsilieris, P. Lampertico, G. Papatheodoridis
Novel Therapies That May Cure Chronic Hepatitis B Virus.
2021 A. Loglio, M. Viganò, P. Lampertico
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis
2022 A. Loglio, P. Ferenci, S.C. UCEDA RENTERIA, C. Tham, C. Scholtes, H. Holzmann, F. van Bömmel, M. Borghi, R. Perbellini, A. Rimondi, E. Farina, E. Trombetta, M. Manunta, L. Porretti, D. Prati, F. Ceriotti, F. Zoulim, A. Bertoletti, P. Lampertico
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension
2022 E. Degasperi, M. Anolli, S.C. UCEDA RENTERIA, D. Sambarino, M. Borghi, R. Perbellini, C. Scholtes, F. Facchetti, A. Loglio, S. Monico, M. Fraquelli, A. Costantino, F. Ceriotti, F. Zoulim, P. Lampertico
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro
2023 M. Rossi, A. Vecchi, C. Tiezzi, V. Barili, P. Fisicaro, A. Penna, I. Montali, S. Daffis, S. Fletcher, A. Gaggar, J. Medley, M. Graupe, L. Lad, A. Loglio, R. Soffredini, M. Borghi, T. Pollicino, C. Musolino, A. Alfieri, F. Brillo, D. Laccabue, M. Massari, C. Boarini, G. Abbati, G. Pedrazzi, G. Missale, P. Lampertico, C. Ferrari, C. Boni
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile